MIDRIXNEO-LUNG: Neoantigen-presenting autologous dendritic cell therapy in resected NSCLC
Prof Karim Vermaelen, medical oncologist from UZ Ghent presents the results of a first-in-human study with an mRNA-loaded dendritic cell vaccine in resected lung cancer patients.
With the educational support of:
